BlackRock’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,316,393
| Closed | -$152M | – | 5564 |
|
|
2025
Q3 | $152M | Sell |
10,316,393
-253,031
| -2% | -$2.58M | ﹤0.01% | 1832 |
|
|
2025
Q2 | $104M | Buy |
10,569,424
+494,080
| +5% | +$4.09M | ﹤0.01% | 2021 |
|
|
2025
Q1 | $73.2M | Buy |
10,075,344
+2,185,245
| +28% | +$19.1M | ﹤0.01% | 2177 |
|
|
2024
Q4 | $61.7M | Buy |
7,890,099
+340,797
| +5% | +$2.81M | ﹤0.01% | 2330 |
|
|
2024
Q3 | $55.9M | Buy |
7,549,302
+533,727
| +8% | +$4.49M | ﹤0.01% | 2407 |
|
|
2024
Q2 | $56.2M | Buy |
7,015,575
+377,591
| +6% | +$3.37M | ﹤0.01% | 2343 |
|
|
2024
Q1 | $77.3M | Buy |
6,637,984
+1,183,788
| +22% | +$13.1M | ﹤0.01% | 2206 |
|
|
2023
Q4 | $60.9M | Buy |
5,454,196
+487,956
| +10% | +$4.49M | ﹤0.01% | 2354 |
|
|
2023
Q3 | $76.7M | Buy |
4,966,240
+316,057
| +7% | +$5.31M | ﹤0.01% | 2145 |
|
|
2023
Q2 | $88.1M | Buy |
4,650,183
+3,400,611
| +272% | +$59.7M | ﹤0.01% | 2127 |
|
|
2023
Q1 | $19M | Buy |
1,249,572
+179,991
| +17% | +$2.35M | ﹤0.01% | 3003 |
|
|
2022
Q4 | $13.6M | Buy |
1,069,581
+159,539
| +18% | +$1.44M | ﹤0.01% | 3240 |
|
|
2022
Q3 | $5.27M | Buy |
910,042
+382,677
| +73% | +$1.68M | ﹤0.01% | 3730 |
|
|
2022
Q2 | $1.7M | Sell |
527,365
-394,865
| -43% | -$1.19M | ﹤0.01% | 4315 |
|
|
2022
Q1 | $3.48M | Buy |
922,230
+70,489
| +8% | +$454K | ﹤0.01% | 4142 |
|
|
2021
Q4 | $11.1M | Buy |
851,741
+119,347
| +16% | +$1.89M | ﹤0.01% | 3609 |
|
|
2021
Q3 | $14.3M | Sell |
732,394
-7,209
| -1% | -$132K | ﹤0.01% | 3492 |
|
|
2021
Q2 | $13.8M | Buy |
739,603
+38,111
| +5% | +$851K | ﹤0.01% | 3518 |
|
|
2021
Q1 | $16.6M | Buy |
701,492
+42,659
| +6% | +$985K | ﹤0.01% | 3283 |
|
|
2020
Q4 | $16.1M | Buy |
658,833
+223,147
| +51% | +$5.7M | ﹤0.01% | 3125 |
|
|
2020
Q3 | $11.2M | Buy |
435,686
+221,709
| +104% | +$7.03M | ﹤0.01% | 3163 |
|
|
2020
Q2 | $4.26M | Sell |
213,977
-3,771
| -2% | -$91.7K | ﹤0.01% | 3587 |
|
|
2020
Q1 | $5.5M | Buy |
217,748
+34,426
| +19% | +$1.01M | ﹤0.01% | 3315 |
|
|
2019
Q4 | $4.82M | Buy |
+183,322
| New | +$5.1M | ﹤0.01% | 3512 |
|
Other funds holding ETNB
BlackRock's ETNB Position: Q4 2025 in Review
BlackRock sold out of 89bio (ETNB) in Q4 2025, closing a stake of 10,316,393 shares — an estimated $152M sold.
BlackRock first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $152M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- BlackRock reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- BlackRock sold 10,316,393 89bio shares in Q4 2025, an estimated $152M.
- BlackRock first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- BlackRock's 89bio position peaked at $152M in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.